Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

77
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
77
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

89
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
89
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

134
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
134
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

675
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
675
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

454
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
454
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

300
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
300

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms for Long-term Retention of Plutonium in the Respiratory Tract: Inferences from Animal and Human Studies.

Health physics·2026
Same author

An international survey of radiological protection in medical research programmes involving human volunteers.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

The Systems of Radiological Protection for Ionizing and Non-Ionizing Radiation.

Health physics·2026
Same author

EURADOS/REMPAN Review on Monitoring and Dosimetry for Radionuclide-contaminated Wounds.

Disaster medicine and public health preparedness·2025
Same author

Dose Coefficients and Reference Bioassay Functions for Intakes of Radionuclides via Contaminated Wounds Using the ICRP OIR Models.

Health physics·2025
Same author

Likelihood Functions for Bioassay Measurements for Development, Selection, and Calibration of Biokinetic Models.

Health physics·2025
Same journal

KRT6A Impairs Radiosensitivity in Cervical Squamous Cell Carcinoma by Enhancing Fatty Acid Synthesis.

Radiation research·2026
Same journal

Chromosomal Instability: A Potential Biomarker of Radiation Response.

Radiation research·2026
Same journal

Antioxidant Probucol Reduces Mortality in Mice Exposed to Lethal Doses of Ionizing Radiation.

Radiation research·2026
Same journal

The Detection of Radiation Effects in the Urine of Rhesus Macaques Using Raman Spectroscopy.

Radiation research·2026
Same journal

Characterization of Radiation-responsive Genes and Transcript Variants under Different Radiation Qualities, Doses and Dose Rates.

Radiation research·2026
Same journal

Methyl Quercetin Inhibits Radiation-induced Senescence and TGF-β1-induced Myofibroblast Differentiation Through Psmad3/TGF-Β Signaling.

Radiation research·2026
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films
12:22

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films

Published on: November 9, 2015

11.4K

Plutonium Systemic Biokinetic Model for Rats.

John A Klumpp1, Deepesh Poudel1, Sara Dumit1

  • 1Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, New Mexico.

Radiation Research
|September 1, 2022
PubMed
Summary
This summary is machine-generated.

A new model describes plutonium distribution in rats after intake, improving on previous americium models. This plutonium (Pu) model better predicts its behavior, aiding decorporation studies.

More Related Videos

Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
08:46

Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications

Published on: April 21, 2022

2.4K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

Related Experiment Videos

Last Updated: Aug 30, 2025

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films
12:22

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films

Published on: November 9, 2015

11.4K
Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
08:46

Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications

Published on: April 21, 2022

2.4K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

Area of Science:

  • Radiopharmaceutical chemistry
  • Pharmacokinetics
  • Computational toxicology

Background:

  • Previous models for americium (Am) distribution used a "cell-membrane limited" pharmacokinetic (PK) approach.
  • This approach was insufficient for accurately modeling plutonium (Pu) distribution and retention data.

Purpose of the Study:

  • To derive a baseline compartmental model for plutonium distribution and retention in rats following systemic intake.
  • To adapt and improve upon existing pharmacokinetic models for better plutonium behavior prediction.

Main Methods:

  • Developed a compartmental model incorporating "free" and "bound" plutonium components in plasma.
  • Utilized a "capillary-wall limited" front-end for bound plutonium transfer, differing from the "cell-membrane limited" approach for free plutonium.
  • Applied Markov Chain Monte Carlo (MCMC) to assess uncertainties in transfer rates.

Main Results:

  • The modified model successfully fits plutonium distribution and retention data for the first 28 days post-intake.
  • Identified distinct pharmacokinetic behaviors for free and bound plutonium, with implications for bone and gastrointestinal tract deposition.
  • Quantified uncertainties in model transfer rates.

Conclusions:

  • The developed compartmental model provides a more accurate representation of plutonium pharmacokinetics in rats.
  • This model structure is valuable for interpreting data from plutonium decorporation studies in experimental animals.
  • The model highlights the importance of differentiating plutonium binding states for accurate toxicokinetic assessment.